Three Measures for the Prevention of Carious Lesions in Preschool Children

NCT ID: NCT02341352

Last Updated: 2015-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Analysis different measures preventive effect on carious Lesions incidence and oral microecological system change of preschool children

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Different caries prevention trials including fluoride vanish, IgY-passive immunotherapy and probiotics lasting 24 months were conducted with a total of 500 children aged 24 to 54 months of age in Lin'an, Zhejiang, China. The trials were cluster- domized .After obtaining parent´s informed consent, preschool children were clinical examinated according to ICDAS-Ⅱ and microbiological tested of saliva at baseline, 1m, 6m, 12m, 18m and 24m. To find the differences of caries incidence and oral microecology change in four groups, dmfs will be assessed and saliva will be analysed in experiment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Only behavioral education for Caregiver

Group Type NO_INTERVENTION

No interventions assigned to this group

fluoride varnish

fluoride varnish every 6 months

Group Type EXPERIMENTAL

fluoride varnish

Intervention Type DRUG

Sodium fluoride 50mg/ml

ImmunoglobulinY

anti-S.mutans Immunoglobulin yolk for everyday use

Group Type EXPERIMENTAL

Immunoglobulin Yolk

Intervention Type BIOLOGICAL

anti-Streptococcus mutans IgY

Probiotics

Probiotics use for 1 months

Group Type EXPERIMENTAL

Probiotics

Intervention Type DIETARY_SUPPLEMENT

2g/day,Lactobacillus rhamnosus HN001, Bifidobacterium lactis Bi-07, Bifidobacterium lactis HN019, maltodextrin, fructose, skimmed milk powder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fluoride varnish

Sodium fluoride 50mg/ml

Intervention Type DRUG

Immunoglobulin Yolk

anti-Streptococcus mutans IgY

Intervention Type BIOLOGICAL

Probiotics

2g/day,Lactobacillus rhamnosus HN001, Bifidobacterium lactis Bi-07, Bifidobacterium lactis HN019, maltodextrin, fructose, skimmed milk powder

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Duraphat(Colgate-palmolive company) Aoliding oral bacteriostatic spray(Hangzhou YaSheng Biotech) Probiotics milk power(Minsheng Pharmaceutical)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* preschool children in good general health
* At least 18 deciduous teeth

Exclusion Criteria

* With major systemic disease or on long-term medication
* Not cooperative and refuse dental treatment
* With a history of extra fluoride supplement
* Take antibiotics for nearly 8 weeks
Minimum Eligible Age

24 Months

Maximum Eligible Age

54 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hangzhou Occupational Disease Prevention Hospital

OTHER

Sponsor Role collaborator

Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xi Chen

Master

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hui Chen

Role: PRINCIPAL_INVESTIGATOR

Department of Conservative Dentistry and Periodontics, Affiliated Hospital of Stomatology, School of Medicine, Zhejiang University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Affiliated Hospital of Stomatology, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Zhang J, Su L, Wang Y, Deng S. Improved High-Throughput Sequencing of the Human Oral Microbiome: From Illumina to PacBio. Can J Infect Dis Med Microbiol. 2020 Dec 11;2020:6678872. doi: 10.1155/2020/6678872. eCollection 2020.

Reference Type DERIVED
PMID: 33381248 (View on PubMed)

Wang Y, Wang S, Wu C, Chen X, Duan Z, Xu Q, Jiang W, Xu L, Wang T, Su L, Wang Y, Chen Y, Zhang J, Huang Y, Tong S, Zhou C, Deng S, Qin N. Oral Microbiome Alterations Associated with Early Childhood Caries Highlight the Importance of Carbohydrate Metabolic Activities. mSystems. 2019 Nov 5;4(6):e00450-19. doi: 10.1128/mSystems.00450-19.

Reference Type DERIVED
PMID: 31690590 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

81371142

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

20120633B14

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2013-8

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.